(-1.20%) 5 046.25 points
(-1.16%) 38 231 points
(-1.59%) 17 383 points
(-0.02%) $82.79
(-1.63%) $1.626
(0.20%) $2 343.00
(0.42%) $27.46
(-0.48%) $911.40
(0.08%) $0.935
(0.15%) $11.00
(-0.12%) $0.801
(-0.32%) $92.03
@ $10.95
Issued: 24 Apr 2024 @ 14:11
Return: -0.46%
Previous signal: Apr 24 - 12:47
Previous signal:
Return: 0.65 %
Live Chart Being Loaded With Signals
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia...
Stats | |
---|---|
Today's Volume | 2.84M |
Average Volume | 7.47M |
Market Cap | 8.78B |
EPS | $0 ( 2024-02-13 ) |
Next earnings date | ( $-0.250 ) 2024-06-26 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 2.07 |
ATR14 | $0.265 (2.43%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-22 | Kumar Rakhi | Buy | 230 548 | Stock Option (Right to Buy) |
2024-04-22 | Kumar Rakhi | Sell | 38 685 | Common Shares |
2024-04-22 | Pulik Richard | Buy | 302 594 | Stock Option (Right to Buy) |
2024-04-22 | Pulik Richard | Buy | 38 685 | Common Shares |
2024-04-20 | Gline Matthew | Sell | 10 945 | Common Shares |
INSIDER POWER |
---|
-96.55 |
Last 100 transactions |
Buy: 3 387 324 | Sell: 180 532 104 |
Volume Correlation
Roivant Sciences Ltd. Correlation
10 Most Positive Correlations | |
---|---|
IMVT | 0.942 |
BKCH | 0.933 |
BNIXU | 0.932 |
NLSP | 0.928 |
WLFC | 0.927 |
CBAY | 0.925 |
TBNK | 0.924 |
EEFT | 0.923 |
NWLI | 0.92 |
LUNA | 0.919 |
10 Most Negative Correlations | |
---|---|
PRSO | -0.923 |
PCRX | -0.92 |
MEDS | -0.912 |
SGLB | -0.912 |
RPID | -0.908 |
BOWXU | -0.907 |
USCB | -0.904 |
UTME | -0.903 |
RIVN | -0.9 |
MOTS | -0.898 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Roivant Sciences Ltd. Correlation - Currency/Commodity
Roivant Sciences Ltd. Financials
Annual | 2023 |
Revenue: | $61.28M |
Gross Profit: | $48.15M (78.58 %) |
EPS: | $-1.730 |
Q3 | 2024 |
Revenue: | $37.14M |
Gross Profit: | $33.47M (90.12 %) |
EPS: | $6.37 |
Q2 | 2024 |
Revenue: | $37.10M |
Gross Profit: | $33.84M (91.20 %) |
EPS: | $-0.400 |
Q1 | 2024 |
Revenue: | $21.62M |
Gross Profit: | $17.41M (80.51 %) |
EPS: | $-0.380 |
Financial Reports:
No articles found.
Roivant Sciences Ltd.
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators